Psychopharmacology and Psychiatry Updates-logo

Psychopharmacology and Psychiatry Updates

Medical

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

Location:

United States

Genres:

Medical

Description:

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

Language:

English


Episodes
Ask host to enable sharing for playback control

Insomnia and Depression: A Tangled Web

6/20/2024
In this episode, we explore the complex relationship between insomnia and major depressive disorder. How does insomnia impact the course and treatment of depression? Join us as we dive into the neurobiology and clinical implications of this fascinating topic with expert Dr. Amit Chopra. Faculty: Amit Chopra, M.D. Host: Richard Seeber, M.D. Learn more about our memberships hereEarn 1.25 CME: Navigating Insomnia in Major Depressive Disorder: Advances in ManagementUnderstanding the Relationship Between Insomnia Disorder and MDD

Duration:00:16:01

Ask host to enable sharing for playback control

ADHD Treatment During Pregnancy: Insights from Denmark

6/15/2024
In this episode, we explore the long-term effects of ADHD medication use during pregnancy on children's development. Can continuing treatment pose risks, or is it safer than previously thought? Join us as we dive into a groundbreaking Danish study that sheds light on this critical question. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership hereEarn 0.5 CMEs: CAP Smart Takes Vol. 16In Utero Exposure to ADHD Medication and Long-Term Offspring Outcomes

Duration:00:09:19

Ask host to enable sharing for playback control

The Power of Nonpharmacologic Therapies in Fibromyalgia

6/10/2024
In this episode, we explore the growing evidence for nonpharmacologic therapies in managing fibromyalgia symptoms. Could a combination of exercise, cognitive–behavioral therapy, and integrative approaches, like acupuncture or yoga, be the key to better outcomes for patients resistant to traditional treatments? Faculty: Daniel Clauw, M.D. Host: Richard Seeber, M.D. Learn more about our memberships hereEarn 0.75 CME: Nociplastic Pain Syndromes: Focus on FibromyalgiaNonpharmacologic Therapies for Fibromyalgia

Duration:00:08:52

Ask host to enable sharing for playback control

Highlights From APA 2024: Key Insights on Psychopharmacology

6/5/2024
In this episode, the editorial team of the Psychopharmacology Institute discusses 3 important topics presented at the APA Annual Meeting: Prescribing psychiatric medications during pregnancy, recent advances in clozapine treatment, and managing eating disorders, namely anorexia nervosa and bulimia nervosa. The episode covers the safety and dose adjustments for medications like SSRIs, lamotrigine, and lithium during pregnancy; early initiation and monitoring of clozapine; and effective treatments, including psychotherapy, olanzapine, and fluoxetine for eating disorders. Hosts: Flavio Guzman, M.D., Paz Badia, M.D., and Lorena Rodriguez, M.D.

Duration:00:18:17

Ask host to enable sharing for playback control

Antidepressants in Pregnancy: Weighing the Evidence

5/31/2024
In this episode, we discuss a new study on maternal depression, antidepressant use, and pregnancy complications. Can antidepressants during pregnancy harm the baby? Dr. Lauren Osborne helps us weigh the risks and benefits. Faculty: Lauren Osborne, M.D. Host: Richard Seeber, M.D. Learn more about our membership hereEarn 0.5 CMEs: Quick Take Vol. 56Neonatal and Pregnancy Complications Following Maternal Depression or Antidepressant Exposure

Duration:00:11:24

Ask host to enable sharing for playback control

Unraveling the Pharmacological Puzzle of Fibromyalgia

5/26/2024
In this episode, we explore the most effective pharmacologic treatments for fibromyalgia, a complex nociplastic pain syndrome. Dr. Daniel Clauw shares his insights on the top drug classes for managing fibromyalgia and discusses why opioids should be avoided. Could the hyperactive endogenous opioid system in fibromyalgia patients explain the ineffectiveness of opioids? Faculty: Daniel Claw, M.D. Host: Richard Seeber, M.D. Learn more about our memberships hereEarn 0.75 CME: Nociplastic Pain Syndromes: Focus on FibromyalgiaPharmacologic Therapies for Fibromyalgia

Duration:00:08:16

Ask host to enable sharing for playback control

Weighing the Evidence: Antipsychotics in Pediatric Anorexia Nervosa

5/21/2024
In this episode, we explore the use of antipsychotic medication in treating children and adolescents with anorexia nervosa. Can these medications play a role in promoting weight gain and reducing comorbid symptoms? Or do the risks outweigh the potential benefits in this vulnerable population? Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership hereEarn 0.5 CME: CAP Smart Takes Vol. 15Antipsychotics in the Treatment of Youth With Anorexia Nervosa

Duration:00:12:22

Ask host to enable sharing for playback control

Beyond the Pain: Diagnosing Fibromyalgia

5/17/2024
In this episode, we dive into the diagnosis of fibromyalgia, a common nociplastic pain syndrome. We explore how to assess widespread pain and associated symptoms and how to understand fibromyalgia as a spectrum rather than a binary diagnosis. How can this nuanced approach help us tailor treatment strategies? Faculty: Daniel Clauw, M.D. Host: Richard Seeber, M.D. Learn more about our memberships hereEarn 0.75 CME: Nociplastic Pain Syndromes: Focus on FibromyalgiaDiagnosing Fibromyalgia

Duration:00:07:16

Ask host to enable sharing for playback control

Informed Consent and SSRIs: Discussing the Risk of Irreversible Sexual Side Effects

5/11/2024
In this episode, we delve into the potential for irreversible sexual dysfunction after SSRI use, based on a large-scale Israeli study. Could a few months or even days of antidepressant treatment lead to permanent erectile issues? Faculty: Paul Zarkowski, M.D. Host: Richard Seeber, M.D. Learn more about our membership hereEarn 0.5 CMEs: Quick Take Vol. 55Risk of Irreversible Post‑SSRI Sexual Dysfunction With Antidepressants

Duration:00:09:52

Ask host to enable sharing for playback control

Mastering Clozapine: Adverse Effect Management

5/6/2024
In this episode, we discuss the management of common adverse effects associated with clozapine treatment, including myocarditis, cardiomyopathy, tachycardia, orthostatic hypotension, and metabolic syndrome. How can clinicians mitigate these risks while optimizing treatment outcomes for patients with treatment-resistant schizophrenia? Faculty: Brian Miller, M.D. Host: Richard Seeber, M.D. Learn more about our memberships hereEarn 1.25 CME: Clozapine: Management and ChallengesManaging Cardiac and Metabolic Adverse Effects of Clozapine

Duration:00:15:27

Ask host to enable sharing for playback control

Preventing Depression and Anxiety Relapse in Youth

5/1/2024
In this episode, we explore relapse prevention strategies for youth with depression and anxiety disorders. Are there effective ways to reduce the risk and prolong the time to relapse? Dr. David Rosenberg discusses the findings of a recent meta-analysis and systematic review on this crucial topic. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership hereEarn 0.5 CMEs: CAP Smart Takes Vol. 15Relapse Prevention Strategies for Depression and Anxiety in Remitted Youth

Duration:00:10:22

Ask host to enable sharing for playback control

Charting the Clozapine Course: Titration and Monitoring

4/26/2024
In this episode, we navigate the complexities of initiating and optimizing clozapine treatment for patients with treatment-resistant schizophrenia. How do you chart the course for successful clozapine therapy while managing side effects and drug interactions? Join us as Dr. Brian Miller shares his expertise and valuable psychopharmacology pearls. Faculty: Brian Miller, M.D. Host: Richard Seeber, M.D. Learn more about our memberships hereEarn 1.25 CMEs: Clozapine: Management and ChallengesInitiating and Optimizing Clozapine

Duration:00:15:03

Ask host to enable sharing for playback control

Smoking and Psychosis: Insights from the PATH Study

4/21/2024
In this episode, we discuss the prevalence of smoking among people with psychosis, based on recent findings from the PATH study. Dr. Oliver Freudenreich shares insights on how clinicians can prioritize smoking cessation in this population. How can we bridge the health outcome disparities faced by our patients with psychosis? Faculty: Oliver Freudenreich, M.D. Host: Richard Seeber, M.D. Learn more about our membership hereEarn 0.75 CMEs: Quick Take Vol. 55Tobacco Use, Nicotine Dependence, and Cessation Among Adults with Psychosis

Duration:00:12:17

Ask host to enable sharing for playback control

Clozapine: The Gold Standard for Treatment-Resistant Schizophrenia

4/16/2024
In this episode, we delve into the use of clozapine for treatment-resistant psychosis and mood disorders. When should clinicians consider clozapine, and what do expert guidelines recommend? Dr. Brian Miller guides us through the evidence and best practices for utilizing this powerful but often underused medication. Faculty: Brian Miller, M.D. Host: Richard Seeber, M.D. Learn more about our memberships hereEarn 1.25 CME: Clozapine: Management and ChallengesUsing Clozapine for Treatment-Resistant Psychosis and Mood Disorders

Duration:00:09:29

Ask host to enable sharing for playback control

Balancing Benefits and Risks: Lithium in Child and Adolescent Psychiatry

4/11/2024
In this episode, we explore the role of lithium in treating pediatric bipolar disorder and conduct disorder. Is lithium a viable option for managing these complex conditions in children and adolescents, or are other medications more effective? Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership hereEarn 0.5 CMEs: CAP Smart Takes Vol. 14Use of Lithium in Pediatric Bipolar Disorders and Externalizing Childhood-Related Disorders

Duration:00:10:55

Ask host to enable sharing for playback control

Orchestrating Nutrition and Medication: Micronutrient Therapy in Practice

4/6/2024
In this episode, we explore real-world clinical cases demonstrating how broad-spectrum micronutrients can complement existing interventions for ADHD, emotional dysregulation, and mood instability. Can close monitoring and expert guidance optimize the integration of nutritional supplementation with pharmacologic treatments to create a harmonious, personalized approach? Faculty: Amelia Villagomez, M.D. Host: Richard Seeber, M.D. Learn more about our membership hereEarn 0.75 CMEs: Broad-Spectrum Micronutrients (BSMs) for Mental Health: What You Need to Know for Clinical UseClinical Cases

Duration:00:09:14

Ask host to enable sharing for playback control

Zuranolone: A New Dawn for Postpartum Depression Treatment

4/1/2024
In this episode, we discuss the groundbreaking FDA approval of zuranolone, the first oral medication specifically targeting postpartum depression. Could zuranolone's novel mechanism of action as an allopregnanolone agonist herald a new era of rapid-onset, targeted treatments for this debilitating condition affecting 1 in 8 new mothers? Faculty: Vivien Burt, M.D. Host: Richard Seeber, M.D. Learn more about our membership hereEarn 0.75 CMEs: Quick Take Vol. 54Zuranolone for the Treatment of Postpartum Depression

Duration:00:12:13

Ask host to enable sharing for playback control

Micronutrients for Psychiatric Disorders: Optimizing Clinical Use

3/27/2024
In this episode, we explore practical clinical tips for using broad-spectrum micronutrient supplements to treat mental health conditions. Can an individual's nutritional needs surpass population standards? Faculty: Amelia Villagomez, M.D. Host: Richard Seeber, M.D. Learn more about our memberships hereEarn 0.75 CME: Broad-Spectrum Micronutrients (BSMs) for Mental Health: What You Need to Know for Clinical UsePractical Tips for Using BSMs in the Clinical Practice

Duration:00:08:00

Ask host to enable sharing for playback control

Olanzapine in Pregnancy: Examining the Risks

3/22/2024
In this episode, we examine whether first-trimester exposure to the antipsychotic olanzapine increases the risk of major fetal malformations. Does stopping medication abruptly also carry risks? Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership hereEarn 0.5 CMEs: CAP Smart Takes Vol. 14Risk of Major Malformations Following First-Trimester Exposure to Olanzapine

Duration:00:10:38

Ask host to enable sharing for playback control

Understanding Safety Risks of Broad-Spectrum Micronutrients

3/17/2024
In this episode, we delve into the safety considerations of using broad-spectrum micronutrient formulas in mental disorder treatment, mainly how these supplements can interact with other medications. Is it safe to use these formulas alongside anesthesia during surgery? Faculty: Amelia Villagomez, M.D. Host: Richard Seeber, M.D. Learn more about our memberships hereEarn 0.75 CME: Broad-Spectrum Micronutrients (BSMs) for Mental Health: What You Need to Know for Clinical UseBSMs and Drug Interactions

Duration:00:06:25